PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2014 results after the market closes on Wednesday, February 18, 2015. The Company will also host a conference call and webcast on Thursday, February 19, 2015 at 9:00 a.m. (ET) to discuss the results with members of the investment community.
Explore related content and topics
Page
Pharmacogenomics
Optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency with minimal adverse effects.
Read More
Page
Pharmacovigilance & Patient Safety
We provide a comprehensive range of drug safety services, minimizing risk and protecting patient well-being from clinical development to…
Read More
Webinar
Practical Implementation of Signal Detection in Iterative Benefit Risk Evaluation
This webcast with PRA Health Sciences' Jacinta Aniagolu-Johnson (Senior Director, Safety and Risk Management) explores how a well defined signal…
View Resource
View all related content and resources for Pharmacovigilance
Explore Insights